SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2107420

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2107420

Latin America Pharmaceutical Products CMO Market, By Service Type, By Product Type, By Therapeutic Area, By Geography

PUBLISHED:
PAGES: 257 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Latin America Pharmaceutical Products CMO Market is estimated to be valued at USD 25.5 Bn in 2026 and is expected to reach USD 38.46 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.95% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 25.5 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.95% 2033 Value Projection: USD 38.46 Bn

Pharmaceutical products CMO provide wide range of manufacturing services, which include contract packaging, quality testing, and development service to pharmaceutical and biotechnology industries. Contract manufacturing organizations offer services from development of biologics to commercial scale production.

Market Dynamics

The Latin America pharmaceutical products CMO market is expected to witness significant growth during the forecast period, owing to the increasing expansion of international pharmaceutical companies in Latin America. For instance, in April 2020, the U.S. pharmaceutical company and French corporation Gennisium Pharma entered into the exclusive agreement under which m8 Pharmaceuticals has the exclusive rights to register and commercialize a more suitable formulation of an already existing orphan drug for apnea in Mexico and Brazil. Moreover, additional pipeline products for the treatment of conditions prevalent in premature newborn patients are also included in this partnership.

Low healthcare expenditure is expected to hinder growth of Latin America pharmaceutical products CMO market. For instance, according to the survey by Brazil's Federal Council of Medicine in 2018, per capita public spending on health care in Brazil did not increase above the country's official inflation, which rose by 80% from 2008 to 2017.

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the Latin America pharmaceutical products CMO market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include BASF SE, Bayer AG, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Novartis AG, Pfizer, Inc., Pisa Farmaceutica, Fresenius SE & Co. KGaA, Takeda Pharmaceutical Company Limited, Ferring Pharmaceuticals, Inc., and Landsteiner Scientific
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The Latin America pharmaceutical products CMO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Latin America pharmaceutical products CMO market

Market Segmentation

  • By Service Type (Revenue, USD Bn, 2021-2033)
  • Contract Manufacturing Services (CMO)
    • Active Pharmaceutical Ingredient (API) Manufacturing
  • Small Molecule APIs
  • Biologic APIs
    • Finished Dosage Form (FDF) Manufacturing
  • Solid Dosage Forms
  • Injectable Dosage Forms
  • Semi-solid Dosage Forms
  • Liquid Dosage Forms
    • Packaging Services
  • Primary Packaging
  • Secondary Packaging
    • Fill-Finish Services
  • Contract Research Services (CRO)
    • Drug Discovery Services
  • Target Identification
  • Lead Optimization
    • Preclinical Research
  • In Vitro Studies
  • In Vivo Studies
    • Clinical Research
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
    • Regulatory Affairs Services
    • Pharmacovigilance Services
    • Medical Writing Services
  • By Product Type (Revenue, USD Bn, 2021-2033)
  • Small Molecule Drugs
  • Biologics
    • Monoclonal Antibodies
    • Recombinant Proteins
    • Vaccines
    • Cell & Gene Therapies
  • Biosimilars
  • By Therapeutic Area
  • Oncology
  • Infectious Diseases
  • Cardiovascular Diseases
  • Neurology
  • Metabolic Disorders
  • Respiratory Diseases
  • Immunology
  • Rare Diseases
  • Others
  • By End User
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Generic Drug Manufacturers
  • Academic & Research Institutes
  • Government Organizations
  • By Region (Revenue, USD Bn, 2021-2033)
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Key Players
  • BASF SE
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Hoffmann-La Roche Ltd.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Pisa Farmaceutica
  • Fresenius SE & Co. KGaA
  • Takeda Pharmaceutical Company Limited
  • Ferring Pharmaceuticals, Inc.
  • Landsteiner Scientific
Product Code: CMI3933

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Service Type
    • Market Snapshot, By Product Type
    • Market Snapshot, By Therapeutic Area
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Product Approval
  • Collaboration/Merge/Acquisition
  • Regulatory Landscape
  • PEST Analysis
  • Porter's Five Forces Analysis
  • Epidemiology
  • Robust Pipeline Analysis

4. Latin America Pharmaceutical Products CMO Market, By Service Type, 2021 - 2033, (USD Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022- 2033
    • Segment Trends
  • Contract Manufacturing Services (CMO)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Active Pharmaceutical Ingredient (API) Manufacturing
    • Small Molecule APIs
    • Biologic APIs
  • Finished Dosage Form (FDF) Manufacturing
    • Solid Dosage Forms
    • Injectable Dosage Forms
    • Semi-solid Dosage Forms
    • Liquid Dosage Forms
  • Packaging Services
    • Primary Packaging
    • Secondary Packaging
  • Fill-Finish Services
  • Contract Research Services (CRO)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Drug Discovery Services
    • Target Identification
    • Lead Optimization
  • Preclinical Research
    • In Vitro Studies
    • In Vivo Studies
  • Clinical Research
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Regulatory Affairs Services
  • Pharmacovigilance Services
  • Medical Writing Services

5. Latin America Pharmaceutical Products CMO Market, By Product Type, 2021 - 2033, (USD Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022- 2033
    • Segment Trends
  • Small Molecule Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Biologics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
      • Monoclonal Antibodies
      • Recombinant Proteins
      • Vaccines
      • Cell & Gene Therapies
  • Biosimilars
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Latin America Pharmaceutical Products CMO Market, By Therapeutic Area, 2021 - 2033, (USD Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022- 2033
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Cardiovascular Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Metabolic Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Respiratory Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Immunology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Rare Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

7. Latin America Pharmaceutical Products CMO Market, By End User, 2021 - 2033, (USD Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022- 2033
    • Segment Trends
  • Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Generic Drug Manufacturers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Government Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

8. Latin America Pharmaceutical Products CMO Market, By Country, 2021 - 2033, (USD Billion)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2022-2033
    • Regional Trends
  • Brazil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
  • Mexico
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
  • Argentina
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
  • Rest Of Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profile
    • BASF SE
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Bayer AG
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Boehringer Ingelheim GmbH
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Hoffmann-La Roche Ltd.
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Merck & Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Pisa Farmaceutica
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Fresenius SE & Co. KGaA
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Takeda Pharmaceutical Company Limited
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Ferring Pharmaceuticals, Inc.
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Landsteiner Scientific
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!